Taro Pharmaceuticals U.S.A., Inc. recalls Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Is
Recalled February 19, 2020 · FDA recall D-0833-2020 · Taro Pharmaceuticals U.S.A
Hazard
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate. · FDA Class I
Sold at
Nationwide in the U.S. and Puerto Rico.
Description
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Product
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
Manufacturer(s)
Taro Pharmaceuticals U.S.A., Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →